Mycobutin Related Clinical Trials
EARNEST Rifabutin Pharmacokinetics (PK) Substudy [Recruiting]
Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers [Completed]
Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa [Completed]
Safety And Efficacy Of Rifabutin In HIV Patients [Active, not recruiting]
Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients [Completed]
Effects of Steady-state TPV/RTV on the Single-dose Pharmacokinetics of Rifabutin and the Effects of Single-dose Rifabutin on the Steady-state Pharmacokinetics of TPV in Healthy Adult Volunteers [Completed]
Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly [Not yet recruiting]
Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam [Completed]
Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061) [Completed]
TMC207 +/- Rifabutin/Rifampin [Completed]
A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc [Completed]
A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects [Terminated]
A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy Participants [Completed]
Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease [Active, not recruiting]
TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB [Completed]
TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz [Completed]
Drug-drug Interaction (DDI) Rifabutin [Completed]
Use of Azithromycin and Rifabutin Administered Three Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease [Active, not recruiting]
TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB [Completed]
Study to Determine the Effects of Nevirapine (VIRAMUNE�) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients [Completed]
A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS [Completed]
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study [Completed]
Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults [Completed]
The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients [Completed]
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [Completed]
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [Completed]
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS [Completed]
Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites [Completed]
A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo [Completed]
The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients [Completed]
Drug Interaction Study [Completed]
Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV [Recruiting]
Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen [Recruiting]
TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen [Completed]
Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications [Completed]
Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS [Completed]
A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS [Completed]
A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients [Completed]
Patients Response to Early Switch To Oral:Osteomyelitis Study [Not yet recruiting]
Brief Bactericidal Activity of Anti-Tuberculosis Drugs [Not yet recruiting]
Assessing PA-824 for Tuberculosis (the APT Trial) [Recruiting]
Research on New Regimens for Retreatment Pulmonary Tuberculosis [Recruiting]
Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis [Completed]
Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis [Recruiting]
Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients [Recruiting]
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105 [Active, not recruiting]
Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis [Completed]
The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study [Completed]
A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections [Completed]
The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection [Completed]
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease [Recruiting]
Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS) [Active, not recruiting]
Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis [Recruiting]
|